Although there have been hypotheses regarding a possible reduction of ascending aortic dilatation in patients with BAV by beta-blockers or angiotensin-converting enzyme (ACE) inhibitors, current clinical evidence does not support a causal association between these drugs and a decreased rate of aortic dilatation [15,16]. The gene discussed is ACE; the disease is Ascending tubular aorta aneurysm.